TTG-108

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTTG-108
Drug Alias NameTTG-108
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionSodium channel protein type X alpha subunit inhibitors
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsPeripheral Nerve Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTetragenetics
China Registration ClassN/A

Develop Information

Active CompaniesTetragenetics
Inactive CompaniesN/A
Active IndicationsPeripheral Nerve Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A